51
|
Guy J, Qi X, Muzyczka N, Hauswirth WW. Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. ARCHIVES OF OPHTHALMOLOGY (CHICAGO, ILL. : 1960) 1999; 117:929-37. [PMID: 10408459 DOI: 10.1001/archopht.117.7.929] [Citation(s) in RCA: 90] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
OBJECTIVE To determine the foci and duration of protein expression following virus-mediated gene transfer to the optic nerve. METHODS A cytomegalovirus (CMV) promoter was linked to a lacZ-SV40 polyA reporter gene or a humanized green fluorescent protein (hgfp) reporter gene, then inserted into a bacterial plasmid containing adeno-associated virus (AAV) terminal repeat sequences. The CMV-lacZ or the CMV-hgfp construct were injected into the vitreous cavity of strain-13 guinea pigs. Controls consisted of eyes injected with AAV without the promoter and reporter elements or eyes that received no injections. The eyes and optic nerves were processed for beta-galactosidase immunohistochemistry and hgfp fluorescence analyses. Cellular transduction at the messenger RNA (mRNA) level was evaluated by in situ reverse transcription-polymerase chain reaction. RESULTS Weekly fundus photography, done for 1 month, documented the absence of any ocular abnormality due to the viral injections. No in vivo hgfp fluorescence of the retina was visualized. Beta-galactosidase histochemical analysis of eye cups that received the lacZ gene construct showed blue lacZ staining of the optic nerve head at 2 weeks. Light microscopy revealed the blue beta-galactosidase reaction product in fibers, glial cells, and blood vessels of the optic nerve head and retrobulbar nerve. Histochemistry showed absence of beta-galactosidase in the optic nerve at 3 to 12 months, but immunochemistry showed the persistence of beta-galactosidase in fibers, glial cells, and blood vessels as late as 1 year after a single ocular injection. In the retina, histochemical staining showed evidence of lacZ at 3 months, but not later. In situ reverse transcription-polymerase chain reaction revealed brown lacZ mRNA reaction product in ganglion cells of the retina. Control eyes that received AAV without the promoter and reporter elements and the eyes that received no viral injections and were processed for beta-galactosidase showed no reporter gene expression in any ocular tissue or cell type. CONCLUSIONS Viral-mediated gene transfer can be successfully accomplished in the optic nerve. Further evaluation is needed to determine whether the level of protein expression at 1 year after injection, which is clearly reduced relative to shorter postinjection time, is sufficient for therapeutic purposes. CLINICAL RELEVANCE We have previously shown that gene therapy with catalase suppressed experimental optic neuritis at 1 month after injection. Viral-mediated gene transfer may be a powerful technique for the treatment of optic neuropathies, particularly for recurrences of optic neuritis, if long-term expression of transduced protein can be demonstrated in the optic nerve.
Collapse
|
52
|
Harmon JP, Purvin VA, Guy J, Aptsiauri N, Sutton GP. Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma. Gynecol Oncol 1999; 73:430-2. [PMID: 10366473 DOI: 10.1006/gyno.1999.5342] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
BACKGROUND Paraneoplastic phenomena, such as retinopathy, may herald an unsuspected gynecologic malignancy. CASE A 75-year-old woman presented to a neuro-ophthalmologist with abrupt onset of unilateral visual loss. A diagnosis of branch retinal artery occlusion was made and she was treated with aspirin. An echocardiogram subsequently revealed atrial dilation and she was placed on coumadin therapy. Her vision worsened and a cancer-associated retinopathy was entertained. A serum cancer-associated retinopathy antibody was detected; subsequent computed tomographies of the abdomen and pelvis revealed findings consistent with a primary ovarian carcinoma. CONCLUSION Patients with unexplained ophthalmologic symptoms may harbor an underlying gynecologic cancer.
Collapse
|
53
|
Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. ARCHIVES OF OPHTHALMOLOGY (CHICAGO, ILL. : 1960) 1999; 117:471-7. [PMID: 10206574 DOI: 10.1001/archopht.117.4.471] [Citation(s) in RCA: 114] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
BACKGROUND Paraneoplastic visual loss is an autoimmune disorder believed to be caused by the remote effects of cancer on the retina (cancer-associated retinopathy [CAR]) or optic nerve. Both disorders may result in rapid and complete blindness. Spontaneous recovery of vision has not been reported. The serum of patients with CAR contains autoantibodies against recoverin, enolase, or unidentified retinal proteins. Autopsy examination results of eyes of blind patients with CAR show complete absence of the retinal neurons involved in phototransduction. Corticosteroids and plasmapheresis are the only treatment options previously described. OBJECTIVE To treat paraneoplastic visual loss. DESIGN AND METHODS Three patients with metastatic cancer developed rapidly progressive loss of vision. The first patient had visual acuity of hand movements in each eye before intravenous immunoglobulin treatment. The second patient had visual acuity of light perception in both eyes. The third patient's visual acuity was 20/400 OD and 20/20 OS. Diagnostic tests included magnetic resonance imaging of the head and cytologic examination of the cerebrospinal fluid to exclude metastasis as the cause of visual loss and then an electroretinogram and serum tests for autoantibodies against retinal antigens to confirm the clinical diagnosis of CAR. Patients 1 and 2 were treated with intravenous immunoglobulin (400 mg/kg per day) for 5 days; however, patient 3 received only a single dose due to adverse effects consisting of shortness of breath and itching. RESULTS Within 24 hours of taking the first dose of intravenous immunoglobulin, the visual acuity of patient 1 improved from hand movements only in both eyes to 20/50 OD and 20/200 OS. After the third day of treatment, visual acuity in the left eye further improved to 20/40. Even with the improved acuity, Goldmann visual field perimetry results showed poor responses in both eyes. However, 2 weeks later there was marked visual field improvement, and visual acuity was maintained at 20/50 OD and 20/40 OS. Patient 2 had no improvements and continued to have light perception in both eyes. Patient 3 had improvements in visual field defects but remained 20/400 OD and 20/20 OS. CONCLUSION Intravenous immunoglobulin may be another treatment option offered to patients with paraneoplastic visual loss in addition to corticosteroids or plasmapheresis because a review of the medical literature has shown no spontaneous improvements of visual function without treatment.
Collapse
|
54
|
Guy J, Willemsen R, Langeveld A, Grosveld F, Drabek D. Murine MHC class II locus control region drives expression of human beta-glucocerebrosidase in antigen presenting cells of transgenic mice. Gene Ther 1999; 6:498-507. [PMID: 10476209 DOI: 10.1038/sj.gt.3300855] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Gaucher disease is the most prevalent lysosomal storage disorder in humans, resulting from an inherited deficiency of the enzyme glucocerebrosidase. Although the enzyme is ubiquitously expressed, cells of the reticuloendothelial system are particularly affected since they accumulate the undigested glucosylceramide substrate through their role in scavenging and breaking down cell debris. Gaucher disease is an attractive target for somatic gene therapy. To test the ability to express the enzyme in the affected cell types we have generated transgenic mice expressing human glucocerebrosidase under the control of the murine major histocompatibility complex (MHC) class II Ead locus control region (LCR). The four transgenic lines express the human enzyme in a copy number-dependent manner, independent of the integration site of the transgene. Over-expression of the human enzyme in mice did not result in any abnormal phenotype or pathology during the period of observation (> 2 years). The enzyme is expressed in B cells, monocytes, dendritic cells, thymic epithelial cells, and macrophages in various tissues: the peritoneal cavity, bone marrow, spleen, kidney, gastrointestinal tract, Kupffer cells in the liver and alveolar macrophages in lungs. Expression in the brain was limited to perivascular macrophages and was not seen in microglial cells. Therefore, the MHC class II LCR could potentially be of use in somatic gene therapy for type 1 Gaucher disease.
Collapse
|
55
|
Jackson MS, Rocchi M, Thompson G, Hearn T, Crosier M, Guy J, Kirk D, Mulligan L, Ricco A, Piccininni S, Marzella R, Viggiano L, Archidiacono N. Sequences flanking the centromere of human chromosome 10 are a complex patchwork of arm-specific sequences, stable duplications and unstable sequences with homologies to telomeric and other centromeric locations. Hum Mol Genet 1999; 8:205-15. [PMID: 9931328 DOI: 10.1093/hmg/8.2.205] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Little is known about sequence organization close to human centromeres, despite empirical and theoretical data which suggest that it may be unusual. Here we present maps which physically define large sequence duplications flanking the centromeric satellites of human chromosome 10, together with a fluorescence in situ hybridization (FISH) analysis of pericentromeric sequence stability. Our results indicate that the duplications on each chromosome arm are organized into two blocks of approximately 250 and 150 kb separated by approximately 300 kb of non-duplicated DNA. The larger proximal blocks, containing ZNF11A, ZNF33A and ZNF37A (10p11) and ZNF11B, ZNF33B and ZNF37B (10q11), are inverted. However, the smaller distal blocks, containing D10S141A (10p11) and D10S141B (10q11), are not. A primate FISH analysis indicates that these loci were duplicated before the divergence of orang-utans from other Great Apes, that a cytogenetically cryptic pericentric inversion may have been involved in the formation of the flanking duplications and that they have undergone further rearrangement in other primate species. More surprising is the fact that sequences across the entire pericentromeric region appear to have undergone unprecedented levels of duplication, transposition, inversion and either deletion or sequence divergence in all primate species analysed. Extrapolating our data to the whole genome suggests that a minimum of 50 Mb of DNA in centromere-proximal regions is subject to an elevated level of mechanistically diverse sequence rearrangements compared with the bulk of genomic DNA.
Collapse
|
56
|
Guy J, Qi X, Hauswirth WW. Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A 1998; 95:13847-52. [PMID: 9811889 PMCID: PMC24923 DOI: 10.1073/pnas.95.23.13847] [Citation(s) in RCA: 50] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
Suppression of oxidative injury by viral-mediated transfer of the human catalase gene was tested in the optic nerves of animals with experimental allergic encephalomyelitis (EAE). EAE is an inflammatory autoimmune disorder of primary central nervous system demyelination that has been frequently used as an animal model for the human disease multiple sclerosis (MS). The optic nerve is a frequent site of involvement common to both EAE and MS. Recombinant adeno-associated virus containing the human gene for catalase was injected over the right optic nerve heads of SJL/J mice that were simultaneously sensitized for EAE. After 1 month, cell-specific catalase activity, evaluated by quantitation of catalase immunogold, was increased approximately 2-fold each in endothelia, oligodendroglia, astrocytes, and axons of the optic nerve. Effects of catalase on the histologic lesions of EAE were measured by computerized analysis of the myelin sheath area (for demyelination), optic disc area (for optic nerve head swelling), extent of the cellular infiltrate, extravasated serum albumin labeled by immunogold (for blood-brain barrier disruption), and in vivo H2O2 reaction product. Relative to control, contralateral optic nerves injected with the recombinant virus without a therapeutic gene, catalase gene inoculation reduced demyelination by 38%, optic nerve head swelling by 29%, cellular infiltration by 34%, disruption of the blood-brain barrier by 64%, and in vivo levels of H2O2 by 61%. Because the efficacy of potential treatments for MS are usually initially tested in the EAE animal model, this study suggests that catalase gene delivery by using viral vectors may be a therapeutic strategy for suppression of MS.
Collapse
|
57
|
O'Brien WJ, Narasimhan J, Guy J, Tom P, Taylor JL. The effects of interferon-alpha and acyclovir on herpes simplex virus type-1 ribonucleotide reductase. Antiviral Res 1998; 38:107-16. [PMID: 9707373 DOI: 10.1016/s0166-3542(98)00016-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Herpes simplex virus-type 1 (HSV-1) encodes both the small (UL40) and large (UL39) subunits of the enzyme, ribonucleotide reductase. Treatment of HSV-1-infected cells with interferon-alpha (IFN-alpha) reduced the levels of both enzyme subunits. Reduced steady state levels of the large subunit were demonstrated by immunoblot using polyclonal antibody specific for the viral enzyme. Reduction in the amount of small subunit was shown by a reduction in the electron spin resonance signal derived from the iron-containing tyrosyl free-radical present in this subunit. Treatment of cells with 100 IU/ml of IFN-alpha decreased levels of both subunits resulting in a reduction in enzyme activity as measured by conversion of CDP to dCDP. The decrease in the amount of the large subunit was not due to a reduction in the level of its mRNA. The combination of IFN-alpha and ACV treatment of human cornea stromal cells did not result in a further reduction in amounts of ribonucleotide reductase relative to that detected with IFN-alpha alone. The IFN-alpha-induced reduction in ribonucleotide reductase activity is the likely cause of decreased levels of dGTP which we have previously demonstrated in IFN-alpha-treated, infected cells.
Collapse
|
58
|
Borel CO, Guy J, Barcik U, Natoli MJ, Vann RD. Effect of hypobaria on ventilatory and CO2 responses to short-term hypoxic exposure in cats. RESPIRATION PHYSIOLOGY 1998; 111:45-53. [PMID: 9496471 DOI: 10.1016/s0034-5687(97)00098-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The effect of hypobaria on the ventilatory response to short-term hypoxia was studied by comparing the respiratory mechanical and inspired CO2 ventilatory responses to hypobaric hypoxia (438 mmHg) with normobaric hypoxia (11.8% FIO2). Fifteen spontaneously breathing, anesthetized cats were divided into three groups of five: time control, normobaric hypoxia and hypobaric hypoxia. Measurements of ventilation, gas exchange, and responses to intermittent CO2 rebreathing were collected over a 4 h period. PaO2 fell to 44.5 +/- 2.7 mmHg, PaCO2 fell to 24.8 +/- 0.9, and pH rose to 7.49 +/- 0.01 in both hypoxic groups. Tidal volume did not change with respect to time or condition, but frequency and ventilation were significantly increased in the hypobaric hypoxic group. The slope of the CO2 response was unchanged over time or by condition. These results suggest that hypobaric hypoxia may alter the pattern of breathing responses to hypoxia but not the CO2-response. If metabolic rate remained constant, these results could be explained by a difference in dead space between hypoxic conditions.
Collapse
|
59
|
Fabling JM, Gan TJ, Guy J, Borel CO, el-Moalem HE, Warner DS. Postoperative nausea and vomiting. A retrospective analysis in patients undergoing elective craniotomy. J Neurosurg Anesthesiol 1997; 9:308-12. [PMID: 9339401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Nausea and vomiting are important complications after craniotomy, for which there are little published epidemiologic data. We retrospectively examined the incidence of postcraniotomy nausea and vomiting to define risk factors. Medical records from 199 adults undergoing elective craniotomy were identified. Data extracted from surgery and the initial 48 hours postoperatively included gender, age, supratentorial versus infratentorial craniotomy, type of anesthesia (general versus monitored anesthesia care), intraoperative fentanyl dose, duration of anesthesia, antiemetic administration intraoperatively and postoperatively, and incidence of postoperative nausea, emesis, and opioid use. Postoperative nausea was recorded in 99 patients (50%) and emesis in 78 patients (39%). Postoperative opioids were administered to 170 patients (85%). Antiemetics were given intraoperatively to 13 patients (7%) and postoperatively to 121 patients (61%). More women (61%) than men (37%) had nausea (P = 0.001); emesis (women = 46%; men = 31%, P = 0.03); and postoperative antiemetic use (women = 69%; men = 51%, P = 0.013). The incidence of postoperative nausea (P = 0.04) and vomiting (P = 0.06) was greater in patients having infratentorial surgery. Emesis was more frequent in younger patients (P = 0.03). Postoperative nausea and vomiting were independent of anesthetic duration, fentanyl dose, or postoperative opioid use and occurred with similar frequency after general anesthesia or monitored anesthesia care. We conclude that postoperative nausea and vomiting occur frequently after craniotomy. Infratentorial surgery, female gender, and younger age are significant risk factors for this complication.
Collapse
|
60
|
Qi X, Guy J, Nick H, Valentine J, Rao N. Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis. Invest Ophthalmol Vis Sci 1997; 38:1203-12. [PMID: 9152240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
PURPOSE To evaluate the role of manganese superoxide dismutase (Mn-SOD) and copper/zinc superoxide dismutase (Cu/Zn-SOD) in cellular protection of the optic nerve against the oxidative injury that contributes to demyelination in experimental allergic encephalomyelitis (EAE). METHODS Immunocytochemistry for Mn-SOD and Cu/Zn-SOD and ultracytochemical localization of hydrogen peroxide (H2O2) were performed on the optic nerves of guinea pigs with EAE and normal guinea pigs. Cell-specific enzyme expression of SOD was quantitated by computerized morphometric analysis. RESULTS Light microscopy showed a perivascular distribution of Mn-SOD-positive cells in the optic nerves of animals with EAE. Electron microscopy showed that the Mn-SOD immunogold was confined exclusively to mitochondria, whereas Cu/Zn-SOD immunogold was found in the cytoplasmic matrix and nucleus of cells of the optic nerve in both animals with EAE and normal animals. Results of quantitative analysis of the optic nerves of animals with EAE showed an 8-fold increase in Mn-SOD immunogold in astroglial cells and a 13-fold increase in microglial/phagocytic cells in comparison with that of normal animals. Increases in Mn-SOD immunogold were contiguous to H2O2-derived reaction product. No increases in Cu/Zn-SOD immunogold were detected in EAE. CONCLUSIONS Increases in Mn-SOD activity in astroglial cells and microglial/phagocytic cells may contribute to the relative sparing of these cells from injury in EAE, whereas the low level of Mn-SOD in oligodendroglial cells and axons may increase their vulnerability to the effects of superoxide-induced oxidative injury that results in demyelination.
Collapse
|
61
|
Abstract
The Approaches to Study Inventory (ASI), developed by Entwistle & Ramsden (1983), was administered to all nursing students at an Australian university (response rate = 67%). The purpose was to find out whether ASI constructs also apply to nursing students and to see whether nursing students change in their study approaches in the course of their nursing education. The ASI was construct validated through factor analysis. While it was possible to reconstruct a majority of the subscales based on individual items, only the meaning and reproducing study orientations were supported. These two orientations also demonstrated satisfactory levels of internal consistency for group comparisons. The authors conclude that the ASI is a useful and robust instrument for use in nursing education with respect to the two main study orientations. Ideally, nursing education should successively pave the way for an increase in meaning orientation scores (deep learning) and a reduction in reproducing orientation scores (surface learning). However, in this study there was no change in study orientations from first to third year. The association between meaning orientation scores and academic performance was weak.
Collapse
|
62
|
Guy J, Hindman BJ, Baker KZ, Borel CO, Maktabi M, Ostapkovich N, Kirchner J, Todd MM, Fogarty-Mack P, Yancy V, Sokoll MD, McAllister A, Roland C, Young WL, Warner DS. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions. Anesthesiology 1997; 86:514-24. [PMID: 9066316 DOI: 10.1097/00000542-199703000-00002] [Citation(s) in RCA: 152] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
BACKGROUND Remifentanil hydrochloride is an ultra-short-acting, esterase-metabolized mu-opioid receptor agonist. This study compared the use of remifentanil or fentanyl during elective supratentorial craniotomy for space-occupying lesions. METHODS Sixty-three adults gave written informed consent for this prospective, randomized, double-blind, multiple-center trial. Anesthesia was induced with thiopental, pancuronium, nitrous oxide/oxygen, and fentanyl (n = 32; 2 micrograms.kg.-1. min-1) or remifentanil (n = 31; 1 mu.kg-1.min-1). After tracheal intubation, infusion rates were reduced to 0.03 microgram.kg-1.min-1 (fentanyl) or 0.2 microgram.kg-1.min-1 (remifentanil) and then adjusted to maintain anesthesia and stable hemodynamics. Isoflurane was given only after specified infusion rate increases had occurred. At the time of the first burr hole, intracranial pressure was measured in a subset of patients. At bone flap replacement either saline (fentanyl group) or remifentanil (approximately 0.2 microgram.kg-1.min-1) were infused until dressing completion. Hemodynamics and time to recovery were monitored for 60 min. Analgesic requirements and nausea and vomiting were observed for 24 h. Neurological examinations were performed before operation and on postoperative days 1 and 7. RESULTS Induction hemodynamics were similar. Systolic blood pressure was greater in the patients receiving fentanyl after tracheal intubation (fentanyl = 127 +/- 18 mmHg; remifentanil = 113 +/- 18 mmHg; P = 0.004). Intracranial pressure (fentanyl = 14 +/- 13 mmHg; remifentanil = 13 +/- 10 mmHg) and cerebral perfusion pressure (fentanyl = 76 +/- 19 mmHg; remifentanil = 78 +/- 14 mmHg) were similar. Isoflurane use was greater in the patients who received fentanyl. Median time to tracheal extubation was similar (fentanyl = 4 min: range = -1 to 40 min; remifentanil = 5 min: range = 1 to 15 min). Seven patients receiving fentanyl and none receiving remifentanil required naloxone. Postoperative systolic blood pressure was greater (fentanyl = 134 +/- 16 mmHg; remifentanil = 147 +/- 15 mmHg; P = 0.001) and analgesics were required earlier in patients receiving remifentanil. Incidences of nausea and vomiting were similar. CONCLUSIONS Remifentanil appears to be a reasonable alternative to fentanyl during elective supratentorial craniotomy.
Collapse
|
63
|
Drabek D, Guy J, Craig R, Grosveld F. The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB1954. Gene Ther 1997; 4:93-100. [PMID: 9081711 DOI: 10.1038/sj.gt.3300366] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The enzyme nitroreductase, isolated from Escherichia coli B, converts CB1954 ((5-aziridin-1-yl)-2,4-dinitro-benzamide) into a cytotoxic DNA interstrand cross-linking agent. The E. coli B gene (nfnB, NTR) encoding nitroreductase (NTR) was cloned into eukaryotic expression vectors. When driven by a CMV promoter, 5-10% of the stably transfected mouse fibroblasts expressed the NTR enzyme. These cells were killed at a concentration of 20 microM CB1954 in comparison to nonexpressing cells which were killed at a much higher concentration (500 microM). We subsequently generated transgenic mice to test the prodrug system in vivo. Nitroreductase was expressed specifically in T cells driven by the control elements of the human CD2 locus. Upon CB1954 treatment, transgenic mice show extensive cell depletion in thymus and spleen (14-16% of normal cell numbers), whereas all other tissues are unaffected by prodrug administration. These results raise the possibility of using the NTR gene in anticancer therapy.
Collapse
|
64
|
Qi X, Guy J. Localization of NADPH diaphorase/nitric oxide synthase in the optic nerve of the normal guinea pig: a light and electron microscopic study. J Comp Neurol 1996; 370:396-404. [PMID: 8799864 DOI: 10.1002/(sici)1096-9861(19960701)370:3<396::aid-cne9>3.0.co;2-#] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The aim of this study is to determine the presence and subcellular distribution of NADPH diaphorase (NADPH-d)/nitric oxide synthase (NOS) in the optic nerve of the normal guinea pig. Optic nerve specimens were stained by NADPH-d histochemistry, and double labeled by combining NADPH-d histochemistry with immunostaining for (a) anti-glial fibrillary acidic protein (GFAP) antibody for recognition of astrocytes, (b) griffonia simplicifilia B4-isolectin (GSA-IB4) horse radish peroxidase (HRP)-conjugate for identification of microglia, or (c) oligodendrocyte-associated antibodies to carbonic anhydrase isoenzyme II (CA-II) or to galactocerebroside (GalC) for visualization of oligodendrocytes. In addition, constitutive NOS (cNOS) and inducible NOS (iNOS) immunostaining were used for colocalization with NADPH-d histochemistry. Light microscopy revealed NADPH-d reaction product in the blood vessels and neuroglia of the unmyelinated optic nerve head and myelinated retrobulbar optic nerve. Double labeling with GFAP immunoperoxidase combined with NADPH-d histochemistry revealed both activities in astrocytes. Microglia were labeled with GSA-IB4 isolectin HRP-conjugate, but they did not have NADPH-d activity. Oligodendroglia were immunolabeled with anti CA-II or anti GalC antibodies, but they did not have NADPH-d activity. Both iNOS and cNOS immunoperoxidase labeled astrocytes, but not microglia or oligodendroglia. Under transmission electron microscopy, NADPH-d reaction product appeared as electron-dense particles. These particles were seen in the cytoplasm of endothelial cells, perivascular smooth muscle cells and fibrous astrocytes. Axons and myelin were devoid of NADPH-d activity. This study demonstrates the existence and cellular distribution of NADPH-d/NOS activity in endothelial cells, perivascular smooth muscle cells and fibrous astrocytes of the optic nerve of the normal guinea pig. The presence of these non-neuronal sources of NOS in the optic nerve provides the foundation for future comparative studies of the functional role of reactive oxygen induced toxicity in disorders affecting the optic nerve.
Collapse
|
65
|
Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70:4646-54. [PMID: 8676491 PMCID: PMC190401 DOI: 10.1128/jvi.70.7.4646-4654.1996] [Citation(s) in RCA: 497] [Impact Index Per Article: 17.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
We constructed gfph, a synthetic version of the jellyfish Aequorea victoria green fluorescent protein (gfp) cDNA that is adapted for high-level expression in mammalian cells, especially those of human origin. A total of 92 base substitutions were made in 88 codons in order to change the codon usage within the gfp10 coding sequence so that it was more appropriate for expression in mammalian cells. We also describe a series of versatile recombinant adeno-associated virus and adenovirus vectors for delivery and expression of genes into mammalian cells and, using these vectors, demonstrate the efficient transduction and expression of the gfph gene in the human cell line 293 and also in vivo, within neurosensory cells of guinea pig eye. Cells infected with recombinant adeno-associated virus-GFPH can be readily sorted by fluorescence-activated cell sorting, suggesting that the newly designed gfph gene could be widely used as a reporter in many gene delivery technologies, including human gene therapy.
Collapse
|
66
|
Adam W, Adye T, Agasi E, Ajinenko I, Aleksan R, Alekseev GD, Alemany R, Allport PP, Almehed S, Amaldi U, Amato S, Andreazza A, Andrieux ML, Antilogus P, Apel WD, Arnoud Y, Åsman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Barbi M, Bardin DY, Baroncelli A, Barring O, Barrio JA, Bartl W, Bates MJ, Battaglia M, Baubillier M, Baudot J, Becks KH, Begalli M, Beilliere P, Belokopytov Y, Benvenuti AC, Berggren M, Bertini D, Bertrand D, Bianchi F, Bigi M, Bilenky MS, Billoir P, Bloch D, Blume M, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borisov G, Bosio C, Botner O, Boudinov E, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Branchini P, Brand KD, Brenke T, Brenner RA, Bricman C, Brown RCA, Bruckman P, Brunet JM, Bugge L, Buran T, Burgsmueller T, Buschmann P, Buys A, Cabrera S, Caccia M, Calvi M, Camacho Rozas AJ, Camporesi T, Canale V, Canepa M, Cankocak K, Cao F, Carena F, Carroll L, Caso C, Castillo Gimenez MV, Cattai A, Cavallo FR, Chabaud V, Charpentier P, Chaussard L, Chauveau J, Checchia P, Chelkov GA, Chen M, Chierici R, Chliapnikov P, Chochula P, Chorowicz V, Chudoba J, Cindro V, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Cossutti F, Crawley HB, Crennell D, Crosetti G, Maestro J, Czellar S, Dahl-Jensen E, Dahm J, Dalmagne B, Dam M, Damgaard G, Dauncey PD, Davenport M, Silva W, Defoix C, Deghorain A, Ricca G, Delpierre P, Demaria N, Angelis A, Boer W, Brabandere S, Clercq C, Vaissiere C, Lotto B, Min A, Paula L, Saint-Jean C, Dijkstra H, Ciaccio L, Djama F, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Drees KA, Dris M, Durand JD, Edsall D, Ehret R, Eigen G, Ekelof T, Ekspong G, Elsing M, Engel JP, Erzen B, Santo M, Falk E, Fassouliotis D, Feindt M, Fenyuk A, Ferrer A, Fichet S, Filippas TA, Firestone A, Fischer PA, Foeth H, Fokitis E, Fontanelli F, Formenti F, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Fuster J, Galloni A, Gamba D, Gandelman M, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gele D, Gerber JP, Gibbs M, Gokieli R, Golob B, Gopal G, Gorn L, Gorski M, Gouz Y, Gracco V, Graziani E, Grosdidier G, Grzelak K, Gumenyuk S, Gunnarsson P, Gunther M, Guy J, Hahn F, Hahn S, Hajduk Z, Hallgren A, Hamacher K, Hao W, Harris FJ, Hedberg V, Henriques R, Hernandez JJ, Herquet P, Herr H, Hessing TL, Higon E, Hilke HJ, Hill TS, Holmgren SO, Holt PJ, Holthuizen D, Hoorelbeke S, Houlden M, Hrubec J, Huet K, Hultqvist K, Jackson JN, Jacobsson R, Jalocha P, Janik R, Jarlskog C, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Jonsson L, Jonsson P, Joram C, Juillot P, Kaiser M, Kapusta F, Karafasoulis K, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Khokhlov Y, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klovning A, Kluit P, Koene B, Kokkinias P, Koratzinos M, Korcyl K, Kourkoumelis C, Kouznetsov O, Kramer PH, Krammer M, Kreuter C, Kronkvist I, Krumstein Z, Krupinski W, Kubinec P, Kucewicz W, Kurvinen K, Lacasta C, Laktineh I, Lamblot S, Lamsa JW, Lanceri L, Lane DW, Langefeld P, Last I, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Lefebure V, Legan CK, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Libby J, Liko D, Lindner R, Lipniacka A, Lippi I, Loerstad B, Loken JG, Lopez JM, Loukas D, Lutz P, Lyons L, MacNaughton J, Maehlum G, Maio A, Malychev V, Marco J, Marco R, Marechal B, Margoni M, Marin JC, Mariotti C, Markou A, Maron T, Martinez-Rivero C, Martinez-Vidal F, Marti i Garcia S, Masik J, Matorras F, Matteuzzi C, Matthiae G, Mazzucato M, Cubbin MM, Kay RM, Nulty RM, Medbo J, Merk M, Meroni C, Meyer S, Meyer WT, Miagkov A, Michelotto M, Migliore E, Mirabito L, Mitaroff WA, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Mundim LM, Murray WJ, Muryn B, Myatt G, Naraghi F, Navarria FL, Navas S, Nawrocki K, Negri P, Neumann W, Neumeister N, Nicolaidou R, Nielsen BS, Nieuwenhuizen M, Nikolaenko V, Niss P, Nomerotski A, Normand A, Novak M, Oberschulte-Beckmann W, Obraztsov V, Olshevski AG, Onofre A, Orava R, Osterberg K, Ouraou A, Paganini P, Paganoni M, Pages P, Palka H, Papadopoulou TD, Papageorgiou K, Pape L, Parkes C, Parodi F, Passeri A, Pegoraro M, Peralta L, Pernegger H, Pernicka M, Perrotta A, Petridou C, Petrolini A, Petrovyck M, Phillips HT, Piana G, Pierre F, Pimenta M, Pindo M, Plaszczynski S, Podobrin O, Pol ME, Polok G, Poropat P, Pozdniakov V, Prest M, Privitera P, Pukhaeva N, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Rames J, Ratoff PN, Read AL, Reale M, Rebecchi P, Redaelli NG, Regler M, Reid D, Renton PB, Resvanis LK, Richard F, Richardson J, Ridky J, Rinaudo G, Ripp I, Romero A, Roncagliolo I, Ronchese P, Roos L, Rosenberg EI, Rosso E, Roudeau P, Rovelli T, Ruckstuhl W, Ruhlmann-Kleider V, Ruiz A, Rybicki K, Saarikko H, Sacquin Y, Sadovsky A, Sahr O, Sajot G, Salt J, Sanchez J, Sannino M, Schimmelpfennig M, Schneider H, Schwickerath U, Schyns MAE, Sciolla G, Scuri F, Seager P, Sedykh Y, Segar AM, Seitz A, Sekulin R, Shellard RC, Siccama I, Siegrist P, Simonetti S, Simonetto F, Sisakian AN, Sitar B, Skaali TB, Smadja G, Smirnov N, Smirnova O, Smith GR, Sokolov A, Solovianov O, Sosnowski R, Souza-Santos D, Spassov T, Spiriti E, Sponholz P, Squarcia S, Stanescu C, Stapnes S, Stavitski I, Stevenson K, Stichelbaut F, Stocchi A, Strauss J, Strub R, Stugu B, Szczekowski M, Szeptycka M, Tabarelli T, Tavernet JP, Tchikilev O, Thomas J, Tilquin A, Timmermans J, Tkatchev LG, Todorov T, Todorova S, Toet DZ, Tomaradze A, Tome B, Tonazzo A, Tortora L, Transtromer G, Treille D, Trischuk W, Tristram G, Trombini A, Troncon C, Tsirou A, Turluer ML, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer B, Ullaland O, Uvarov V, Valenti G, Vallazza E, Velde CV, Apeldoorn GW, Dam P, Doninck WK, Eldik J, Vassilopoulos N, Vegni G, Ventura L, Venus W, Verbeure F, Verlato M, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vrba V, Wahlen H, Walck C, Waldner F, Weierstall M, Weilhammer P, Weiser C, Wetherell AM, Wicke D, Wickens JH, Wielers M, Wilkinson GR, Williams WSC, Winter M, Witek M, Woschnagg K, Yip K, Yushchenko O, Zach F, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zimin NI, Zito M, Zontar D, Zucchelli GC, Zumerle G. Study of rareb decays with the DELPHI detector at LEP. ACTA ACUST UNITED AC 1996. [DOI: 10.1007/s002880050238] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
67
|
O'Brien WJ, Segundo AP, Guy J, Dorn EM, Taylor JL. Herpetic stromal disease: response to acyclovir/steroid therapy. ACTA OPHTHALMOLOGICA SCANDINAVICA 1996; 74:265-70. [PMID: 8828724 DOI: 10.1111/j.1600-0420.1996.tb00089.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The efficacy of combined acyclovir and steroid therapy in the treatment of herpetic stromal disease was evaluated by clinical evaluation of disease, the rebound of disease following termination of therapy, and the recovery of virus and viral DNA from corneas in a rabbit model. Therapy with acyclovir alone produced a significant reduction in corneal thickness in 10% of eyes. Addition of steroid to acyclovir therapy decreased the severity of stromal disease as measured by corneal thickness and increased the frequency of response to treatment to 63% of eyes. All eyes receiving acyclovir alone experienced rebound of disease following termination of therapy. Combined therapy increased the severity of rebound of corneal disease. Virus was recovered from cell cultures established after recovery from rebound in 50% of untreated and treated eyes. Viral DNA was detected by PCR in five of the nine corneal cultures which did not produce infectious virus.
Collapse
|
68
|
Abreu P, Adam W, Adye T, Agasi E, Ajinenko I, Aleksan R, Alekseev GD, Alemany R, Allport PP, Almehed S, Amaldi U, Amato S, Andreazza A, Andrieux ML, Antilogus P, Apel WD, Arnoud Y, Åsman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Barbi M, Barbiellini G, Bardin DY, Baroncelli A, Barring O, Barrio JA, Bartl W, Bates MJ, Battaglia M, Baubillier M, Baudot J, Becks KH, Begalli M, Beilliere P, Belokopytov Y, Benvenuti AC, Berggren M, Bertrand D, Bianchi F, Bigi M, Bilenky MS, Billoir P, Bloch D, Blume M, Blyth S, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borisov G, Bosio C, Bosworth S, Botner O, Boudinov E, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Branchini P, Brand KD, Brenke T, Brenner RA, Bricman C, Brillault L, Brown RCA, Bruckman P, Brunet JM, Bugge L, Buran T, Burgsmueller T, Buschmann P, Buys A, Cabrera S, Caccia M, Calvi M, Camacho Rozas AJ, Camporesi T, Canale V, Canepa M, Cankocak K, Cao F, Carena F, Carroll L, Caso C, Castillo Gimenez MV, Cattai A, Cavallo FR, Cerrito L, Chabaud V, Chapkin M, Charpentier P, Chaussard L, Chauveau J, Checchia P, Chelkov GA, Chen M, Chierici R, Chliapnikov P, Chochula P, Chorowicz V, Chudova J, Cindro V, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Cossutti F, Crawley HB, Crennell D, Cresetti G, Maestro JC, Czellar S, Dahl-Jensen E, Dahm J, Dalmagne B, Dam M, Damgaard G, Dauncey PD, Davenport M, Silva W, Defoix C, Deghorain A, Ricca G, Delpierre P, Demaria N, Angelis A, Boer W, Brabandere S, Clercq C, Vaissiere C, Lotto B, Min A, Paula L, Saint-Jean C, Dijkstra H, Ciaccio L, Djama F, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Drees KA, Dris M, Edsall D, Ehret R, Eigen G, Ekelof T, Ekspong G, Elsing M, Engel JP, Ershaidat N, Erzen B, Santo ME, Falk E, Fassouliotis D, Feindt M, Fenyuk A, Ferrer A, Filippas TA, Firestone A, Fischer PA, Foeth H, Fokitis E, Fontanelli F, Formenti F, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Fuster J, Galloni A, Gamba D, Gandelman M, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gele D, Gerber JP, Gibbs M, Gokieli R, Golob B, Gopal G, Gorn L, Gorski M, Gouz Y, Gracco V, Graziani E, Grosdidier G, Grzelak K, Gumenyuk S, Gunnarsson P, Gunther M, Guy J, Hahn F, Hahn S, Hajduk Z, Hallgren A, Hamacher K, Hao W, Harris FJ, Hedberg V, Henriques R, Hernandez JJ, Herquet P, Herr H, Hessing TL, Higon E, Hilke HJ, Hill TS, Holmgren SO, Holt PJ, Holthuizen D, Hoorelbeke S, Houlden M, Huet K, Hultqvist K, Jackson JN, Jacobsson R, Jalocha P, Janik R, Jarlskog C, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Jonsson L, Jonsson P, Joram C, Juillot P, Kaiser M, Kapusta F, Karafasoulis K, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klovning A, Kluit P, Koene B, Kokkinias P, Koratzinos M, Korcyl K, Kostioukhine V, Kourkoumelis C, Kouznetsov O, Kramer PH, Krammer M, Kreuter C, Kronkvist I, Krumstein Z, Krupinski W, Kubinec P, Kucewicz W, Kurvinen K, Lacasta C, Laktineh I, Lamblot S, Lamsa JW, Lanceri L, Lane DW, Langefeld P, Lapin V, Last I, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Lefebure V, Legan CK, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Liko D, Lindner R, Lipniacka A, Lippi I, Loerstad B, Loken JG, Lopez JM, Loukas D, Lutz P, Lyons L, MacNaughton J, Maehlum G, Maio A, Malychev V, Mandl F, Marco J, Marco R, Marechal B, Margoni M, Marin JC, Mariotti C, Markou A, Maron T, Martinez-Rivero C, Martinez-Vidal F, Marti i Garcia S, Masik J, Matorras F, Matteuzzi C, Matthiae G, Mazzucato M, Mc Cubbin M, Mc Kay R, Mc Nulty R, Medbo J, Merk M, Meroni C, Meyer S, Meyer WT, Michelotto M, Migliore E, Mirabito L, Mitaroff WA, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Mundim LM, Murray WJ, Muryn B, Myatt G, Naraghi F, Navarria FL, Navas S, Nawrocki K, Negri P, Neumann W, Neumeister N, Nicolaidou R, Nielsen BS, Nieuwenhuizen M, Nikolaenko V, Niss P, Nomerotski A, Normand A, Novak M, Oberschulte-Beckmann W, Obraztsov V, Olshevski AG, Onofre A, Orava R, Ostankov A, Osterberg K, Ouraou A, Paganini P, Paganoni M, Pages P, Palka H, Papadopoulou TD, Papageorgiou K, Pape L, Parkes C, Parodi F, Passeri A, Pegoraro M, Pernegger H, Pernicka M, Perrotta A, Petridou C, Petrolini A, Petrovyck M, Phillips HT, Piana G, Pierre F, Pimenta M, Pindo M, Plaszczynski S, Podobrin O, Pol ME, Polok G, Poropat P, Pozdniakov V, Prest M, Privitera P, Pukhaeva N, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Ratoff PN, Read AL, Reale M, Rebecchi P, Redaelli NG, Regler M, Reid D, Renton PB, Resvanis LK, Richard F, Richardson J, Ridky J, Rinaudo G, Ripp I, Romero A, Roncagliolo I, Ronchese P, Roos L, Rosenberg EI, Rosso E, Roudeau P, Rovelli T, Ruckstuhl W, Ruhlmann-Kleider V, Ruiz A, Rybicki K, Saarikko H, Sacquin Y, Sadovsky A, Sajot G, Salt J, Sanchez J, Sannino M, Schimmelpfennig M, Schneider H, Schwickerath U, Schyns MAE, Sciolla G, Scuri F, Seager P, Sedykh Y, Segar AM, Seitz A, Sekulin R, Shellard RC, Siccama I, Siegrist P, Simonetti S, Simonetto F, Sisakian AN, Sitar B, Skaali TB, Smadja G, Smirnov N, Smirnova O, Smith GR, Sosnowski R, Souza-Santos D, Spassov T, Spiriti E, Sponholz P, Squarcia S, Stanescu C, Stapnes S, Stavitski I, Stichelbaut F, Stocchi A, Strauss J, Strub R, Stugu B, Szczekowski M, Szeptycka M, Tabarelli T, Tavernet JP, Tchikilev O, Tilquin A, Timmermans J, Tkatchev LG, Todorov T, Todorova S, Toet DZ, Tomaradze A, Tome B, Tonazzo A, Tortora L, Transtromer G, Treille D, Trischuk W, Tristram G, Trombini A, Troncon C, Tsirou A, Turluer ML, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer B, Ullaland O, Uvarov V, Valenti G, Vallazza E, Velde C, Apeldoorn GW, Dam P, Doninck WK, Eldik J, Vassilopoulos N, Vegni G, Ventura L, Venus W, Verbeure F, Verlato M, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vrba V, Wahlen H, Walck C, Weierstall M, Weilhammer P, Weiser C, Wetherell AM, Wicke D, Wickens JH, Wielers M, Wilkinson GR, Williams WSC, Winter M, Witek M, Woschnagg K, Yip K, Zach F, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zimin NI, Zito M, Zontar D, Zuberi R, Zucchelli GC, Zumerle G. Mean lifetime of theB s 0 meson. ACTA ACUST UNITED AC 1996. [DOI: 10.1007/bf02906957] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
69
|
Coulter JB, Cox J, Goodacre T, Harrison N, Hilton A, Griffin G, Guy J, Jefferies A, Leigh N, Marston A. Training of overseas qualified doctors in Britain. Training programmes in countries overseas should be supported. BMJ (CLINICAL RESEARCH ED.) 1996; 312:311. [PMID: 8611801 PMCID: PMC2349915 DOI: 10.1136/bmj.312.7026.311b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
|
70
|
Adamus G, Aptsiauri N, Guy J, Heckenlively J, Flannery J, Hargrave PA. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 1996; 78:120-9. [PMID: 8625554 DOI: 10.1006/clin.1996.0021] [Citation(s) in RCA: 112] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Cancer-associated retinopathy (CAR) is an uncommon paraneoplastic disease in which degeneration of the retina occurs as a remote effect of cancer in a distant part of the body. Immunoreactivity of sera from CAR patients and controls have been analyzed. Immunostaining of human retinal proteins showed that a soluble protein of Mr approximately 46 kDa (p46) is labeled by antibodies from several CAR patients with various types of cancer (lung, breast, bladder, prostate, salivary gland, and gastrointestinal tract cancer and chronic lymphocytic leukemia). These sera did not show reactivity with the 23-kDa protein previously associated with CAR. To identify and further characterize p46, the retinal protein was purified to homogeneity by anion-exchange chromatography and preparative gel electrophoresis. Protein sequence analysis of the peptides from p46 revealed a high homology with human enolase, an important glycolytic enzyme. Although enolase has been previously identified as a product of several types of tumors, and enolase activity has been detected in the sera of some cancer patients, the existence of autoantibodies directed to enolase has not been described. This is the first report of the presence of serum antibodies to retinal enolase in the patients with cancer and the CAR syndrome. When antibodies of specific isotypes (IgG, IgM, and IgA) were measured, IgG1 isotype was dominant. The significance of these antibodies for the disease process is under investigation.
Collapse
|
71
|
Peter CP, Guy J, Shea M, Bagdon W, Kline WF, Hayes WC. Long-term safety of the aminobisphosphonate alendronate in adult dogs. I. General safety and biomechanical properties of bone. J Pharmacol Exp Ther 1996; 276:271-6. [PMID: 8558442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Alendronate (4-amino-1-hydroxybutylidene bisphosphonate, ALN) is an aminobisphosphonate that is being developed for the treatment of diseases characterized by increased bone resorption. The purpose of this study was to assess the long-term safety of ALN with special emphasis on bone strength and bone morphology. Thirty-two (16 males and 16 females) 83- to 86-week-old beagle dogs were treated p.o. for up to 3 years with ALN at 0.00, 0.25, 0.5 or 1.0 mg/kg/day. The following parameters of toxicity were assessed: physical signs, body weight, ophthalmology, radiographic evaluation of bone, electrocardiography, hematology, clinical chemistry, urinalysis, necropsy including organ weight assessment, histopathology and biomechanical testing of bone. There were no apparent compound-related alterations in any of the above mentioned parameters except the expected changes (related to the pharmacological activity of ALN) in serum phosphorus and Ca concentrations and in the histology of bones with active endochondral bone formation (rib). There were mild transient reductions in the serum phosphorus and Ca concentrations at the 1.0 mg/kg/day dose level during the early part of the study. There was a dose-dependent delay in bone remodeling in the ribs of all dogs treated with ALN. There was no similar change in the tibia. Most importantly, there were no spontaneous fractures and there were no changes in the structural properties of femoral or vertebral bone. The total ALN content of bone in an average dog (10 kg) after 3 years of treatment with approximately five items of the intended dose for the treatment of osteoporosis was approximately 8 mg, which is only 0.001% of total bone mass (700 g). Introduction.
Collapse
|
72
|
O'Brien WJ, Palmer ML, Guy J, Taylor JL. Endothelial barrier function and Na+/K(+)-ATPase pump density in herpetic stromal disease. Invest Ophthalmol Vis Sci 1996; 37:29-36. [PMID: 8550332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
PURPOSE Corneal edema is a significant component of the various forms of herpes simplex virus type 1 (HSV-1)-induced stromal disease. Maintenance of corneal thickness, a reflection of corneal hydration, depends on a physical barrier formed by endothelial cell-cell junctions and by the activity of Na+/K(+)-ATPase pumps that regulate ion flux and thus influence water movement through this cell layer. These functions were measured in corneas with increased corneal thickness caused by HSV-1-induced stromal disease to determine their contribution to the pathogenesis of the edema. METHODS Stromal disease with corneal edema was induced in rabbits by intrastromal injection of the RE strain of HSV-1. At various times after infection, during the development of and recovery from stromal disease, endothelial barrier function and Na+/K(+)-ATPase pump sites were measured in excised rabbit corneas. RESULTS The endothelial permeability coefficient, Ktrans, for 14C-dextran, 3H-inulin, and 14C-mannitol, were not altered significantly during periods of maximal corneal edema and stromal disease. Endothelial Na+/K(+)-ATPase pump density, as measured by ouabain binding, showed a statistically significant (P < 0.05) decrease in HSV-1-infected corneas during peak edema compared to mock antigen-injected or uninjected control corneas. Pump density returned to baseline values by 24 days after infection, concurrent with the resolution of corneal edema. CONCLUSIONS These results indicate that corneal endothelial barrier function was not altered in this form of HSV-1-induced stromal edema; however, pump density was reduced significantly.
Collapse
|
73
|
Abstract
Length-of-stay (LOS) reduction is a strategy encouraged at all levels of health care to manage within a resource limited environment. However, few organizations have attempted to quantitatively understand the impact of reducing LOS. This study examines the relationship between reducing LOS and cost through a retrospective, medical records analysis of three surgical procedures (appendectomy, cholecystectomy and caesarean section) at an Ontario community hospital Department of Surgery. Hypotheses are presented and a methodology is described. The results are discussed with a focus on the factors that hospitals, administrators and physicians might consider in a LOS reduction program.
Collapse
|
74
|
Abreu P, Adam W, Adye T, Agasi E, Ajinenko I, Aleksan R, Alekseev GD, Allport PP, Almehed S, Almeida FML, Alvsvaag SJ, Amaldi U, Andreazza A, Antilogus P, Apel WD, Apsimon RJ, Arnoud Y, Asman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Bardin DY, Barker GJ, Baroncelli A, Barring O, Barrio JA, Bartl W, Bates MJ, Battaglia M, Baubillier M, Baudot J, Becks KH, Begalli M, Beilliere P, Beltran P, Benvenuti AC, Berggren M, Bertrand D, Bianchi F, Bigi M, Bilenky MS, Billoir P, Bjarne J, Bloch D, Blocki J, Blyth S, Bocci V, Bogolubov PN, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borisov G, Bosio C, Bostjancic B, Bosworth S, Botner O, Boudinov E, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Braibant S, Branchini P, Brand KD, Brenner RA, Briand H, Bricman C, Brillault L, Brown RCA, Brunet JM, Bugge L, Buran T, Buys A, Buytaert JAMA, Caccia M, Calvi M, Camacho Rozas AJ, Campion R, Camporesi T, Capale V, Cankocak K, Cao F, Carena F, Carrilho P, Carroll L, Cases R, Caso C, Castillo Gimenez MV, Cattai A, Cavallo FR, Cerrito L, Chabaud V, Chan A, Chapkin M, Charpentier P, Chaussard L, Chauveau J, Checchia P, Chelkov GA, Chliapnikov P, Chorowicz V, Chrin JTM, Cindro V, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Cosmo G, Cossutti C, Couchot F, Crawley HB, Crennell D, Crosetti G, Cuevas Maestro J, Czellar S, Dahl-Jensen E, Dahm J, Dalmagne B, Dam M, Damgaard G, Daubie E, Daum A, Dauncey PD, Davenport M, Davies J, Silva W, Defoix C, Delpierre P, Demaria N, Angelis A, Boeck H, Boer W, Brabandere S, Clercq C, Fez Laso MDM, Vaissiere C, Lotto B, Min A, Paula L, Saint-Jean C, Diikstra H, Ciaccio L, Diama F, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Dris M, Dufour Y, Dupont F, Edsall D, Ehret R, Ekelof T, Ekspong G, Elsing M, Engel JP, Ershaidat N, Espirito Santo M, Fassouliotis D, Feindt M, Fenyuk A, Ferrer A, Filippas TA, Firestone A, Foeth H, Fokitis E, Fontanelli F, Formenti F, Fousset JL, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Furstenau H, Fuster J, Gamba D, Gandelman M, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gele D, Gerber JP, Giacomelli P, Gillespie D, Gokieli R, Golob B, Golovatyuk VM, Gomez Y Cadenas JJ, Gopal G, Gorn L, Gorski M, Gracco V, Grard F, Graziani E, Grosdidier G, Gunnarsson P, Guy J, Haedinger U, Hahn F, Hahn M, Hahn S, Haider S, Hajduk Z, Hakansson A, Hallgren A, Hamacher K, Hao W, Harris FJ, Hedberg V, Henriques R, Hernandez JJ, Hernando JA, Herquet P, Herr H, Hessing TL, Higon E, Hilke HJ, Hill TS, Holmgren SO, Holt PJ, Holthuizen D, Honore PF, Houlden M, Hrubec J, Huet K, Hultqvist K, Ioannou P, Iversen PS, Jackson JN, Jacobsson R, Jalocha P, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Jonker M, Jonsson L, Juillot P, Kaiser M, Kalmus G, Kapusta F, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klovning A, Kluit P, Koch-Mehrin A, Koehne JH, Koene B, Kokkinias P, Koratzinos M, Korcyl K, Korytov AV, Kostioukhine V, Kourkoumelis C, Kouznetsov O, Kramer PH, Krammer M, Kreuter C, Krolikowski J, Kronkvist I, Krupinski W, Kulka K, Kurvinen K, Lacasta C, Laktineh I, Lambropoulos C, Lamsa JW, Lanceri L, Langefeld P, Lapin V, Last I, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Levy JM, Lieb E, Liko D, Lindner R, Lipniacka A, Lippi I, Loerstad B, Lokajicek M, Loken JG, Lopez-Fernandez A, Lopez Aguera MA, Los M, Loukas D, Lozano JJ, Lutz P, Lyons L, Maehlum G, Maillard J, Maio A, Maltezos A, Mandl F, Marco J, Marechal B, Margoni M, Marin JC, Mariotti C, Markou A, Maron T, Marti S, Martinez-Rivero C, Martinez-Vidal F, Matorras F, Matteuzzi C, Matthiae G, Mazzucato M, Cubbin MM, Kay RM, Nulty RM, Medbo J, Meroni C, Meyer WT, Michelotto M, Migliore E, Mikulec I, Mirabito L, Mitaroff WA, Mitselmakher GV, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Murray WJ, Muryn B, Myatt G, Naraghi F, Navarria FL, Negri P, Nemecek S, Neumann R, Nicolaidou R, Nielsen BS, Niss P, Nomerotski A, Normand A, Obraztsov V, Olshevski AG, Orava R, Osterberg K, Ouraou A, Paganini P, Paganoni M, Pain R, Palka H, Papadopoulou TD, Pape L, Parodi F, Passeri A, Pegararo M, Pennanen J, Peralta L, Pernegger H, Pernicka M, Perrotta A, Petridou C, Petrolini A, Phillips HT, Piana G, Pierre F, Pimenta M, Plaszczynski S, Podobrin O, Pol ME, Polok G, Poropat P, Pozdniakov V, Prest M, Privitera P, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Rames J, Ratoff PN, Read AL, Reale M, Rebecchi P, Redaelli NG, Regler M, Reid D, Renton PB, Resvanis LK, Richard F, Richardson J, Ridky J, Rinaudo G, Ripp I, Romero A, Roncagliolo I, Ronchese P, Roos L, Rosenberg EI, Rosso E, Roudeau P, Rovelli T, Ruckstuhl W, Ruhlmann-Kleider V, Ruiz A, Rybicki K, Saarikko H, Sacquin Y, Sajot G, Salt J, Sanchez J, Sannino M, Schael S, Schneider H, Schyns MAE, Sciolla G, Scuri F, Segar AM, Seitz A, Sekulin R, Seufert R, Shellard RC, Siccama I, Siegrist P, Simonetti S, Simonetto F, Sisakian AN, Skaali TB, Smadja G, Smirnov N, Smirnova O, Smith GR, Sosnowski R, Souza-Santos D, Spassov T, Spiriti E, Squarcia S, Staeck H, Stanescu C, Stapnes S, Stavitski I, Stavropoulos G, Stepaniak K, Stichelbaut F, Stocchi A, Strauss J, Straver J, Strub R, Stugu B, Szczekowski M, Szeptycka M, Tabarelli T, Tchikilev O, Theodosiou GE, Thome Z, Tilquin A, Timmermans J, Timofeev VG, Tkatchev LG, Todorov T, Toet DZ, Tomaradze A, Tome B, Torassa E, Tortora L, Transtromer G, Treille D, Trischuk W, Tristram G, Troncon C, Tsirou A, Tsyganov EN, Turala M, Turluer ML, Tuuva T, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer B, Ueberschaer S, Ullaland O, Uvarov V, Valenti G, Vallazza E, Valls Ferrer JA, Velde C, Apeldoorn GW, Dam P, Heijden M, Doninck WK, Eldik J, Vaz P, Vegni G, Ventura L, Venus W, Verbeure F, Verlato M, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vollmer M, Voutilainen M, Wahlen H, Walck C, Wehr A, Weierstall M, Weilhammer P, Wetherell AM, Wickens JH, Wielers M, Wilkinson GR, Williams WSC, Winter M, Witek M, Wormser G, Woschnagg K, Yip K, Yushchenko O, Zach F, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zimin NI, Zito M, Zontar D, Zuberi R, Zumerle G. A study of radiative muon-pair events at Z0 energies and limits on an additional Z′ gauge beson. ACTA ACUST UNITED AC 1995. [DOI: 10.1007/bf01578669] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
75
|
McGrath BJ, Guy J, Borel CO, Friedman AH, Warner DS. Perioperative management of aneurysmal subarachnoid hemorrhage: Part 2. Postoperative management. Anesth Analg 1995; 81:1295-302. [PMID: 7486121 DOI: 10.1097/00000539-199512000-00031] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|